Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
280
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia

Zhangdi Xu1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Bihui Pan1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Yue Li1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Yi Xia1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Jinhua Liang1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Yilin Kong1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Xinyu Zhang1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Jing Tang1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Li Wang1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Jianyong Li1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Wei Xu1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4208-7477View further author information
ORCID Icon &
Jiazhu Wu1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China;2 Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China;3 Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 1541-1553 | Received 17 Dec 2022, Accepted 27 Mar 2023, Published online: 26 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.